The goal of conventional cancer treatments is to kill cancer cells. While this current approach is often successful, it has two major drawbacks: the potential for cancer cells to become resistant to the drugs and relapse, as well as damage to healthy cells that can cause serious side effects.
The KAIST team took a completely different approach by targeting the root causes of cancer development. They created a digital replica of the gene network involved in the transformation pathways of normal cells, allowing them to simulate and analyze the complex gene interactions that regulate cell transformation. Through simulations, the team identified key molecular switches that could potentially revert colon cancer cells back to normal.
This research has profound implications, as it could lead to new cancer treatments that have the potential to reduce side effects and the likelihood of relapse. This innovative approach marks a major shift in cancer treatment, opening the way for safer and more effective therapies, according to News Medical.